Physicians and nurses seeking CE credit are encouraged to register with our partner, Physicians Education Resource (https://www.gotoper.com) and view this activity at https://education.gotoper.com//activity/tnbc21ccatp. Program Description Triple-negative breast cancer (TNBC) is aggressive and…
September 14, 2021 Supplements and Featured Publications, Strategies for Effective Cardiovascular Risk Management Through Lipid Management: A Transitional Approach From Hospital to Home, This publication was sponsored and written in partnership…
May 27, 2021 Supplements and Featured Publications, Considerations for Future Management of Autoimmune Therapies, This publication was written in partnership with and paid for by Pfizer Inc. The landscape for autoimmune…
Babette S Edgar, PharmD, MBA, FAMCP; Adam S Cheifetz, MD; Simon M Helfgott, MD; Gideon P Smith, MD, MPH, PhD; Tina Bandekar, RPh; Adam Hoye-Simek, PharmD; YuQian Liu, PharmD, RPh;…
JHOP – August 2020 Vol 10, No 4 – HOPA Corner By Marielle Fares, PharmD, BCGP, MBA; and the Hematology/Oncology Pharmacy Association (HOPA) Standards Committee: Bernadette B. Heron, PharmD, BCOP, Chair; Sol…
Oncoloytic viruses are an emerging class of cancer therapeutics that may provide a new strategy against malignant tumors. Oncoloytic viruses (OVs) are an emerging class of cancer therapeutics that may…
Research on combination therapies involving human papillomavirus-targeted vaccines and immunotherapies continues to expand in phase 2 and 3 trials in patients with head and neck squamous cell carcinoma. Robert L….
© 2022 Science Notes.
